AzTrials
AzTrials

Trauma ChestNCT05025150

Point-of-Care Ultrasound for Pediatric Thoracic Trauma: A Multi-Institutional Trial

An observational study of Trauma Chest and Pediatric ALL, run by Sutter Health at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The objective of the proposed study is to investigate the diagnostic accuracy of ED POCUS in pediatric traumatic thoracic injuries including traumatic pneumothorax, hemothorax, lung contusion, rib fractures, and pulmonary edema (from submersion injury). Read more about this study

Who is it for?
Ages 0 to 21 years
Conditions the study is for
Trauma Chest, Pediatric ALL
How many people
1,020 participants
Where
1 siteUnited States
Study dates
11 Aug 2019to 8 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 21 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: * Suspected penetration injury to neck, chest or abdomen * Falls >10 feet or more than 3 times of the child's height * Suspected spinal cord injury with neurological deficits * Pedestrian or cyclist hit or run over by car at >20mph * Motor vehicle collision (MVC) at high speed >50mph or with ejection of occupant * MVC with death of another occupant or prolonged extrication time or significant intrusion to passenger compartment. * Crash or flip of motorized vehicle with separation of rider from vehicle * High voltage electrical injury (>220V) * Hanging * Submersion injury * Trauma mechanism with cardiac arrest or hypotension adjusted for age * Explosion injury * Treating physician discretion on patients otherwise not meeting any of the above criteria

Who may be able to join

  • Eligible subjects will be children 0 to 21 years of age presenting to the participating PEDs meeting trauma activation criteria and with suspected thoracic injury.

Who cannot join

  • Congenital or acquired cardiopulmonary or osteogenic conditions rendering POCUS ineffective, foreign body/ barrier to lung ultrasound of which removal is contraindicated, subjects under law-enforcement custody, and subjects deemed unsuitable by treating clinicians.

Trial locations and contacts

1 site in 1 country.

Samuel Lam, MD, MPH contact

916 887 1130

docp2slam@gmail.com

United States1 site, 1 recruiting
  • Sutter Medical Center Sacramento

    Sacramento, California, 95816

    Samuel Lam, MD

    Recruiting

Other trials in United States

About this study

The objective of the proposed study is to investigate the diagnostic accuracy of ED POCUS in pediatric traumatic thoracic injuries including traumatic pneumothorax, hemothorax, lung contusion, rib fractures, and pulmonary edema (from submersion injury). This will be a prospective, multicenter, observational study of children 0-21 years of age presenting to the participating pediatric emergency departments for suspected traumatic thoracic injury. Results of POCUS will be compared to that of chest X-ray, final clinical diagnosis, computed tomography (CT) or magnetic resonance imaging (MRI). Study hypotheses are that POCUS is highly accurate (90-95%) when compared to chest X-ray, and moderately accurate (~80%) when compared to CT or MRI in diagnosing these conditions.

Keywords
Ultrasonography
Medical subject headings
Thoracic Injuries, Precursor Cell Lymphoblastic Leukemia-Lymphoma

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy of POCUS as compared to chest X-ray in detecting injuries

    Measured: 7-10 days

Secondary outcomes (2)
  1. Compare the accuracy of POCUS to cross sectional imaging (CT or MRI).

    Measured: 7-10 days

  2. Compare the accuracy of POCUS to chest X-ray or final clinical diagnosis (if no other imaging is performed).

    Measured: 7-10 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Aug 2021
  2. Study start11 Aug 2019
  3. Primary completion8 Aug 2025 (estimated)
  4. Study completion8 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,020 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05025150
Sponsor's protocol ID
2019.091EXP
Status last verified
Nov 2023
First submitted
21 Aug 2021
Last updated
28 Nov 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Trauma Chest and Pediatric ALL, run by Sutter Health at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Samuel Lam, MD, MPH (916 887 1130, docp2slam@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy of POCUS as compared to chest X-ray in detecting injuries (time frame: 7-10 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in